UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Method for Improved Intraoperative Blood Loss Estimates
Completed
- Conditions
- Improved Intraoperative Blood Loss Estimates
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 47
- Registration Number
- NCT01634828
- Locations
- 🇺🇸
University of Utah, Salt lake City, Utah, United States
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer
Completed
- Conditions
- Neoplasms
- First Posted Date
- 2012-06-13
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 32
- Registration Number
- NCT01618344
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer
- First Posted Date
- 2012-06-07
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- University of Utah
- Registration Number
- NCT01614184
Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance
Phase 2
Completed
- Conditions
- Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
- Interventions
- Procedure: Breast cancer surgery
- First Posted Date
- 2012-06-07
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 52
- Registration Number
- NCT01614210
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
MotionLoc Study, Femur Fractures
Completed
- Conditions
- Fracture of the Distal Femur
- Interventions
- Device: Periarticular Locking Plate (NCB, Zimmer)Device: MotionLoc Screw
- First Posted Date
- 2012-06-05
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 2
- Registration Number
- NCT01612208
Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Phase 2
Completed
- Conditions
- Patients at Risk for Melanoma
- Interventions
- Other: Placebo arm
- First Posted Date
- 2012-06-05
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 100
- Registration Number
- NCT01612221
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Physical Activity and Functioning in Home Dialysis Patients
Not Applicable
Completed
- Conditions
- Diabetes
- Interventions
- Other: exercise training
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2016-11-17
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 120
- Registration Number
- NCT01602718
Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma
Phase 1
Completed
- Conditions
- Recurrent Glioma
- Interventions
- First Posted Date
- 2012-04-19
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 22
- Registration Number
- NCT01580969
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
Not Applicable
Completed
- Conditions
- Soft Tissue Sarcoma
- Interventions
- Radiation: MRI-DCE
- First Posted Date
- 2012-04-12
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 16
- Registration Number
- NCT01575951
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Biomechanical Assessment of Femoroacetabular Impingement
- Conditions
- Femoro Acetabular Impingement
- First Posted Date
- 2012-04-12
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 36
- Registration Number
- NCT01575964
- Locations
- 🇺🇸
University of Utah Orthopaedic Center, Salt Lake, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath